Search research articles
Contact Us
Filters
Showing results (61-70 of 129) with videos related to
Page
of 13
Sort By:
Cancer Immunology Research
|
November 13, 2014
Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomide
Duane A Mitchell, Elias J Sayour, Elizabeth Reap, et al.
Oncoimmunology
|
February 16, 2017
Systemic activation of antigen-presenting cells via RNA-loaded nanoparticles
Elias J Sayour, Gabriel De Leon, Christina Pham, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2012
Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma
Bryan D Choi, Chien-Tsun Kuan, Mingqing Cai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2007
Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function
Peter E Fecci, Hidenobu Ochiai, Duane A Mitchell, et al.
Cancer Research
|
March 17, 2006
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma
Peter E Fecci, Duane A Mitchell, John F Whitesides, et al.
Journal of Neuro-Oncology
|
August 28, 2015
Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma
Smita K Nair, Timothy Driscoll, David Boczkowski, et al.
Pediatric Blood & Cancer
|
October 7, 2020
Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial
Jason Fangusaro, Duane A Mitchell, Mehmet Kocak, et al.
Case Reports in Pathology
|
September 17, 2025
A Rare Presentation of Adult Primary Leptomeningeal Medulloblastoma: Case Report
Grace E Hey, Megan E H Still, Rachel S F Moor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2014
Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells
Smita K Nair, Gabriel De Leon, David Boczkowski, et al.
Molecular Therapy. Methods & Clinical Development
|
February 8, 2024
Expanded specific T cells to hypomutated regions of the SARS-CoV-2 using mRNA electroporated antigen-presenting cells
Elizabeth Ogando-Rivas, Paul Castillo, Changlin Yang, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 129) with videos related to
Sort By:
Page
of 13
Cancer Immunology Research
|
November 13, 2014
Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomide
Duane A Mitchell, Elias J Sayour, Elizabeth Reap, et al.
Oncoimmunology
|
February 16, 2017
Systemic activation of antigen-presenting cells via RNA-loaded nanoparticles
Elias J Sayour, Gabriel De Leon, Christina Pham, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2012
Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma
Bryan D Choi, Chien-Tsun Kuan, Mingqing Cai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2007
Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function
Peter E Fecci, Hidenobu Ochiai, Duane A Mitchell, et al.
Cancer Research
|
March 17, 2006
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma
Peter E Fecci, Duane A Mitchell, John F Whitesides, et al.
Journal of Neuro-Oncology
|
August 28, 2015
Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma
Smita K Nair, Timothy Driscoll, David Boczkowski, et al.
Pediatric Blood & Cancer
|
October 7, 2020
Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial
Jason Fangusaro, Duane A Mitchell, Mehmet Kocak, et al.
Case Reports in Pathology
|
September 17, 2025
A Rare Presentation of Adult Primary Leptomeningeal Medulloblastoma: Case Report
Grace E Hey, Megan E H Still, Rachel S F Moor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2014
Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells
Smita K Nair, Gabriel De Leon, David Boczkowski, et al.
Molecular Therapy. Methods & Clinical Development
|
February 8, 2024
Expanded specific T cells to hypomutated regions of the SARS-CoV-2 using mRNA electroporated antigen-presenting cells
Elizabeth Ogando-Rivas, Paul Castillo, Changlin Yang, et al.
Page
of 13